Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mail-Order Rx Ruling In Missouri Helps Anti-PBM Efforts On Hill

Executive Summary

A federal appeals court ruling upholding Missouri's ban on incentives to use mail-order pharmacies gives retail pharmacy groups a timely talking point as they advocate a Medicare drug benefit bill with equal prescription copays for community and mail-order pharmacies.

You may also be interested in...



PBM Regulation Bills To Be Introduced In 14 States, NCPA Says

Legislation providing for oversight of pharmacy benefit management company activities will be introduced in 14 states, National Community Pharmacists Association Exec VP Calvin Anthony told the NCPA annual meeting Oct. 14 in Philadelphia.

PBM Regulation Bills To Be Introduced In 14 States, NCPA Says

Legislation providing for oversight of pharmacy benefit management company activities will be introduced in 14 states, National Community Pharmacists Association Exec VP Calvin Anthony told the NCPA annual meeting Oct. 14 in Philadelphia.

House Medicare Rx Bill Could Be Ready For Floor Vote In October

The House Energy & Commerce and Ways & Means Committees plan to introduce a joint Medicare prescription drug benefit bill in late September, which could allow floor action in October.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS038444

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel